Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2349-2351

  Ranger, Gurpreet Singh ^a,b   Thomas, Valerie ^a   Jewell, Andrew ^a   Mokbel, Kefah ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b BASILDON HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Cyclooxygenase 2; Metastases

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CYCLOOXYGENASE 2; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASM METASTASIS; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 4444305435     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sasco AJ: Breast cancer and the environment. Horm Res 60(3): 50, 2003.
2. Cotterchio M, Krieger N, Steingart A and Buchan G: Nonsteroidal anti inflammatory drugs (NSAID) use and breast cancer. SER Abstract, Am J Epidemiol 151: 572, 2000.
3. Khuder SA and Mutgi AB: Breast cancer and NSAID use: a metaanalysis. Brit J Cancer 84(9): 1188-92, 2001.
4. Singh-Ranger G and Mokbel K: Role of cyclooxygenase-2 (COX-2) expression in breast cancer, and implications of COX-2 inhibition. Eur J Surg Oncol 28(7): 729-37, 2002.
5. Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H and Isola J: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62(3): 632-5, 2002.
6. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J and Koki AT: Cyclooxygenase-2 is expressed in human pulmonary, colonic and mammary tumours. Cancer 89(12): 2637-45, 2000.
7. Half E, Tang XM, Gwyn K, Sahin A, Wathen K and Sinicrope FA: Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 62(6): 1676-81, 2002.
8. Kirkpatrick K, Ogunkolade W, Elkak A, Bustin S, Jenkins P, Ghilchik M and Mokbel K: The mRNA expression of cyclooxygenase-2 (CPOX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Curr Med Res Opin 18(4): 237-41, 2002.
9. Ellis IO, Dowsett M, Bartlett J, Walker R, Cooke T, Gullick W, Gusterson B, Mallon E and Barrett Lee P: Recommendations for HER2 testing in the UK. J Clin Pathol 53: 890-92, 2000.
10. Leake R, Barnes D, Pinder S, Ellis I, Anderson L, Anderson T, Adamson R, Rhodes T, Miller K and Walker R: Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. J Clin Pathol 53: 634-5, 2000.
11. Singh-Ranger G, Kirkpatrick KL, Clark GM and Mokbel K: Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Curr Med Res Opin 19(2): 131-4, 2003.
12. Davies G, Salter J, Hills M, Martin LA, Sacks N and Dowsett M: Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. Clin Cancer Res 9(7): 2651-6, 2003.
13. Howe LR, Subbaramaiah K, Brown AMC and Dannenberg AJ: Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocrine-Related Cancer 8: 97-114, 2001.
14. Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, Saito S, Tsuruo T, Shibata Y and Nagawa H: Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer 83(3): 324-8, 2000.
15. Jackson JR, Seed MP, Kircher CH, Willoughby DA and Winkler JD: The codependence of angiogenesis and chronic inflammation. FASEB J 11(6): 457-65, 1997.
16. Lala PK, Al-Mutter N and Orucevic A: Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HEJ mice. Int J Cancer 73(3): 371-80, 1997.
17. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ and Seibert K: Antiangiogenic and antitumour activities of cyclooxygenase-2 inhibitors. Cancer Res 60: 1306-11, 2000.
18. Dormond O, Foletti A, Paroz C et al: NSAIDs inhibit αVβ3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. Nature Medicine 7(9): 1041-7, 2001.